Trial intelligence / Profile preview

Keppra in elderly patients with seizures and cognitive impairment

NCT01318408Phase 4Completed

Sponsor
Drexel University
Start
Nov 2006
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of levetiracetam in epilepsy, sponsored by Drexel University. Primary endpoints: Mini-Mental State Examination at 12 weeks and Alzheimer's Disease Assessment Scale-Cognitive Subscale at 12 weeks. Started Nov 2006; status: completed.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT01318408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01318408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call